Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
5.20
-0.02 (-0.38%)
May 17, 2024, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for GLUE stock have an average target of 11, which predicts an increase of 111.54% from the current stock price of 5.20.
Analyst Consensus: Buy
* Price targets were last updated on Feb 15, 2024.
Analyst Ratings
The average analyst rating for GLUE stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | +111.54% | Feb 15, 2024 |
JP Morgan | JP Morgan | Buy Maintains $31 → $11 | Buy | Maintains | $31 → $11 | +111.54% | Oct 19, 2023 |
Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +111.54% | Aug 11, 2023 |
Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +111.54% | May 12, 2023 |
Credit Suisse | Credit Suisse | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +111.54% | Mar 17, 2023 |
Financial Forecast
Revenue This Year
3.03M
Revenue Next Year
3.63M
from 3.03M
Increased by 19.99%
EPS This Year
-2.45
from -2.63
EPS Next Year
-2.30
from -2.45
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 18.7M | 18.7M | 17.9M | 368.6M | 671.0M |
Avg | 3.0M | 3.6M | 9.1M | 131.3M | 276.9M |
Low | n/a | n/a | n/a | n/a | 19.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 517.6% | 391.6% | 3,959.8% | 411.1% |
Avg | - | 20.0% | 150.0% | 1,346.1% | 110.9% |
Low | - | - | - | - | -85.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.97 | -1.50 | -1.29 | 1.49 | 4.75 |
Avg | -2.45 | -2.30 | -1.91 | -1.06 | 0.23 |
Low | -2.84 | -2.95 | -2.45 | -2.40 | -2.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.